Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

GSK Investigational Site, New York

GSK Investigational Site, Pittsburgh

GSK Investigational Site, Philadelphia

GSK Investigational Site, Baltimore

GSK Investigational Site, Durham

GSK Investigational Site, Madrid

GSK Investigational Site, Madrid

GSK Investigational Site, Atlanta

GSK Investigational Site, Hollywood

GSK Investigational Site, Nashville

GSK Investigational Site, Lexington

GSK Investigational Site, Columbus

GSK Investigational Site, Iowa City

GSK Investigational Site, Chicago

GSK Investigational Site, St Louis

GSK Investigational Site, Houston

GSK Investigational Site, Denver

GSK Investigational Site, Duarte

GSK Investigational Site, Stanford

GSK Investigational Site, Sacramento

GSK Investigational Site, La Jolla

GSK Investigational Site, Salt Lake City

GSK Investigational Site, Toronto

GSK Investigational Site, Montreal

GSK Investigational Site, Amsterdam

GSK Investigational Site, Groningen

GSK Investigational Site, Rotterdam

GSK Investigational Site, Utrecht

GSK Investigational Site, Barcelona

GSK Investigational Site, London

GSK Investigational Site, Manchester